Journals / Akdeniz Tıp Dergisi / 2015 / Cilt: 1 - Sayı: 2

No-Refl ow Phenomenon: Is it the End of the Story?

No-Refl ow Fenomeni: Hikayenin Sonu mu?

Pages
89–93
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Prevention in patients with clinical and angiographic high risk factors seems to be the mainstay strategy instead of using the present treatment options.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ineffi cient myocardial perfusion in spite of successful accomplishment of epicardial coronary artery patency is referred to as the no-refl ow phenomenon.
📊
Key Findings & Data:Intracoronary drug administration, manual thrombus aspiration and avoiding strategies that cause endothelial injury are the main principles of no-refl ow treatment.
💡
Conclusion & Impact:Prevention in patients with clinical and angiographic high risk factors seems to be the mainstay strategy instead of using the present treatment options.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Ineffi cient myocardial perfusion in spite of successful accomplishment of epicardial coronary artery patency is referred to as the no-refl ow phenomenon. No-refl ow occurrence during the progression of acute myocardial infarction worsens the prognosis. There are many defi nitions of no-refl ow depending on the diagnostic imaging modality. Intracoronary drug administration, manual thrombus aspiration and avoiding strategies that cause endothelial injury are the main principles of no-refl ow treatment. Prevention in patients with clinical and angiographic high risk factors seems to be the mainstay strategy instead of using the present treatment options.

Özet

Epikardiyal koroner arterde açıklığın elde edilmesine rağmen miyokard perfüzyonunun yeterli düzeyde sağlanamaması durumu no-Refl ow Fenomeni olarak isimlendirilmektedir. Akut miyokard infarktüsü sırasında gelişen no-refl ow prognozu olumsuz yönde etkilemektedir. Kullanılan tanısal görüntüleme yöntemlerine bağlı olarak farklı tanımlamaları mevcuttur. İntrakoroner uygulanan farmakolojik ajanlar, manuel trombüs aspirasyonu ve anjiyoplasti sırasında endotel hasarını arttıracak stratejilerden kaçınılması tedavinin temel prensiplerini oluşturmaktadır. Etkin tedavisinin olmaması nedeniyle klinik ve anjiyografi k risk faktörleri olan hastalarda no-refl ow gelişimini önlemeye yönelik stratejilerin uygulanması en önemli tedavi yaklaşımı olmayı sürdürmektedir.

🔖

Cite This Article

DOĞAN, U. (2022). No-Refl ow Phenomenon: Is it the End of the Story?. Akdeniz Tıp Dergisi, Cilt: 1 - Sayı: 2, 89–93. https://ajindex.com/articles/434536

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Keeley EC, Boura JA, Grines Cl. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
  2. Krug A, DuMesnil de Rochemont W, Korb G. Blood supply of the myocardium after temporary coronary occlusion. Circ Res 1966;19:57-62.
  3. Kloner RA, Ganote CE, Jenning RB. The "no-refl ow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-508.
  4. Durante A, Camici PG. Novel insights into an "old" phenomenon: the no refl ow. Int J Cardiol 2015;187:273-80
  5. Tranum-Jensen J, Janse MJ, Fiolet WT, Krieger WJ, D'Alnoncourt CN, Durrer D. Tissue osmolality, cell swelling, and reperfusion in acute regional myocardial ischemia in the isolated porcine. Circ Res 1981;49:364-81.
  6. Reffelmann T, Kloner RA. The no-refl ow phenomenon: A basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol 2006;101:359 -72. Bolli R, Jeroudi MO, Patel BS, DuBose CM, Lai EK, Roberts R, McCay PB. Direct evidence that oxygen- derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci USA 1989; 86: 4695-99.
  7. Ambrosio G, Tritto I. Reperfusion injury: Experimental evidence and clinical implications. Am Heart J 1999;138: S69 -75. Skyschally A, Leineweber K, Gres P, Haude M, Erbel R, Heusch G. Coronary microembolization. Basic Res Cardiol 2006;101:373- 82. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial No- Refl ow in humans. J Am Coll Cardiol 2009;54:281-92.
  8. Yip HK, Chen MC, Chang HW, et al. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: Predictors of slow-fl 2002;122:1322-32. The TIMI Study Group. The thrombolysis in myocardial infarction [TIMI] trial. Phase I fi ndings. N Engl J Med 1985;312:932- 6. van't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F; Zwolle Myocardial Infarction Study Group. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: Myocardial blush grade. Circulation 1998;97:2302- 6. Schröder R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation 2004;110:e506 -10. Iliceto S, Marangelli V, Marchese A, Amico A, Galiuto L, Rizzon P. Myocardial contrast echocardiography in acute myocardial infarction. Pathophysiological background and clinical applications. Eur Heart J 1996;17:344